Ashish Bondre

Serving notice period | Executive - R&D API at Biocon | Chemical Engineer | Process Engineer | B.Tech, D\'BATU

Role: Executive at Biocon
Location: Bengaluru, IN
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Ashish Bondre

Chemical Engineer specializing in Pharmaceutical Manufacturing | Pilot Plant Scale-Up | Process Design | USP & DSP | Technical Service | Process Safety B.Tech Chemical Engineering, Dr. Babasaheb Ambedkar Technological University, Lonere, Maharashtra (September 2021) Currently serving as an Executive at Biocon Ltd, Bangalore, contributing to API R&D and Pilot Plant scale-up technologies. Actively seeking opportunities in Process Design Engineering, Project Engineering, Technical Service, Technology Transfer, and Process Safety Engineering within the Chemical Engineering domain. Skilled in leveraging chemical engineering principles to optimize manufacturing processes, enhance efficiency, and ensure compliance with industry regulations. Passionate about driving innovation, problem-solving, and collaborating cross-functionally to deliver impactful solutions in pharmaceutical manufacturing. Open to networking and discussing potential opportunities in the field of Chemical Engineering. Let\'s connect!

Experience

Executive
Biocon
Apr 2022 — Present · Bengaluru, IN

Education

Dr. Babasaheb Ambedkar Technological University
Bachelor of Technology
2017 — 2021

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@biocon.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Biocon

Biotechnology Research · 12K employees · Bangalore, Karnataka, India

Fraudulent Recruitment Advisory: Biocon and its subsidiaries never charge candidates any fee at any stage of recruitment. Learn how to identify and report fraudulent job offers: https://www.biocon.com/fraudulent-recruitment-advisory/ Biocon Limited (BSE: 532523, NSE: BIOCON) is a global biopharmaceutical company driven by its purpose to provide affordable, life-changing medicines to patients worldwide. Headquartered in Bengaluru, India, Biocon addresses some of the world’s most pressing healthcare challenges across chronic and non-communicable diseases by offering both biosimilars and generics at scale across geographies. Through this diversified portfolio, Biocon focuses on areas of high unmet need, spanning key therapy areas including diabetes, oncology, obesity, cardiovascular diseases, immunology, ophthalmology, and bone health. The Company has pioneered several industry firsts that have helped shape the global biosimilars landscape. To date, the company has commercialized 12 biosimilar products and 30+ generic formulations globally. It has robust research and development pipeline of 20+ biosimilar assets, as well as GLP-1 peptides and other complex generics. With an integrated lab-to-patient model, Biocon brings together research and development, manufacturing, and commercial capabilities to ensure reliable and scalable supply of medicines. The company operates in more than 120 countries, supported by seven manufacturing sites, three R&D sites, 18 offices worldwide, and a workforce of over 9,500 employees. Biocon has been included in the S&P Global Sustainability Yearbook 2026 for the fourth consecutive year, underscoring its commitment to sustainable and responsible growth.

biocon.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.